Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,750 | 30 | 66.8% |
| Travel and Lodging | $24,881 | 94 | 16.3% |
| Consulting Fee | $24,298 | 11 | 16.0% |
| Food and Beverage | $1,398 | 34 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $134,264 | 144 | $0 (2024) |
| Lilly USA, LLC | $10,163 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $7,608 | 4 | $0 (2022) |
| Lucid Diagnostics Inc. | $62.93 | 2 | $0 (2021) |
| PFIZER INC. | $37.00 | 1 | $0 (2018) |
| Intersect ENT, Inc. | $36.31 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $22.80 | 2 | $0 (2017) |
| HOLOGIC INC | $21.65 | 1 | $0 (2020) |
| Abbott Laboratories | $20.72 | 1 | $0 (2020) |
| AIMMUNE THERAPEUTICS, INC. | $18.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $139.49 | 2 | Merck Sharp & Dohme LLC ($120.67) |
| 2023 | $5,953 | 11 | Merck Sharp & Dohme LLC ($5,953) |
| 2022 | $2,611 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,550) |
| 2021 | $8,120 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,058) |
| 2020 | $10,342 | 6 | Merck Sharp & Dohme Corporation ($5,500) |
| 2019 | $13,816 | 15 | Merck Sharp & Dohme Corporation ($13,816) |
| 2018 | $27,297 | 34 | Merck Sharp & Dohme Corporation ($21,880) |
| 2017 | $84,047 | 93 | Merck Sharp & Dohme Corporation ($83,933) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $120.67 | General |
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $4,290.00 | General |
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $87.08 | General |
| 07/27/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.99 | General |
| 07/27/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $53.42 | General |
| 07/27/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $53.06 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $514.69 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $335.00 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $254.84 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $141.96 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $123.33 | General |
| 05/17/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.69 | General |
| 06/27/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $61.23 | General |
| 03/29/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| 12/15/2021 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $19.30 | General |
| 11/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,870.00 | General |
| 11/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,870.00 | General |
| 10/20/2021 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $43.63 | General |
| 05/19/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 05/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,317.50 | General |
| 09/04/2020 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| 09/04/2020 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| 07/18/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/05/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 22 | 85 | $14,390 | $5,875 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 41 | $7,790 | $3,449 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 44 | $6,600 | $2,426 | 36.8% |
About Dr. Scott Conard, MD
Dr. Scott Conard, MD is a Family Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831161546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Conard, MD has received a total of $152,327 in payments from pharmaceutical and medical device companies, with $139.49 received in 2024. These payments were reported across 169 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,750).
As a Medicare-enrolled provider, Conard has provided services to 22 Medicare beneficiaries, totaling 85 services with total Medicare billing of $5,875. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dallas, TX
- Active Since 02/06/2006
- Last Updated 08/02/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831161546
Products in Payments
- JARDIANCE (Drug) $9,400
- PROPEL (Device) $36.31
- ANORO (Drug) $22.80
- Proclaim Family of SCS IPGs (Device) $20.72
- ZENPEP (Drug) $18.82
- BEVYXXA (Drug) $17.65
- UTIBRON (Drug) $15.75
- LINZESS (Drug) $11.45
- BELSOMRA (Drug) $10.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dallas
Dr. Joe Blumenau, M.d., F.a.a.f.p, M.D., F.A.A.F.P
Family Medicine — Payments: $437,740
Chrisette Dharmagunaratne, M.d, M.D
Family Medicine — Payments: $325,780
Andrew Applewhite, Md, MD
Family Medicine — Payments: $83,645
Shiwali Rai, Md, MD
Family Medicine — Payments: $43,143
Dr. Paul Worrell, D.o, D.O
Family Medicine — Payments: $36,341
Ashley Olsin, Fnp, FNP
Family Medicine — Payments: $35,888